dose switching from semaglutide to tirzepatide Switching from Semaglutide to Tirzapetide

If you stick to a schedule, it will become a habit, and youll be less likely to make mistakes

For example, the SURMOUNT-1 trial showed average weight loss of up to 20.9% with tirzepatide, while the STEP 1 trial for semaglutide showed an average loss of around 14.9%, demonstrating tirzepatide's higher efficacy

The first GIP receptor antagonist was introduced in 1986 ( Figure 3 ), and in recent years, the truncated and deactivated form of GIP, GIP(3-30)NH 2 , has proven to be a potent and specific GIP receptor antagonist in humans in high concentrations, and suitable for studies of endogenous GIP physiology and pathophysiology (14) ( Table 1 )

Al estimular estos receptores, la tirzepatida aumenta la secrecin de insulina cuando los niveles de glucosa estn elevados, reduce la liberacin de glucagn (una hormona que eleva el azcar en sangre) y disminuye el apetito al actuar sobre los centros de saciedad en el cerebro

The GI side effects, while potentially improved with BPC-157 support, may still occur

& Garca-Cceres, C